Thylakoid intracapillary proliferative glomerulonephritis, also known as membranoproliferative nephritis, is characterized by hematuria, proteinuria, and renal insufficiency under the naked eye or under the microscope.
Thylakoid intracapillary proliferative glomerulonephritis is mainly characterized by thickening of glomerular basement membrane, proliferation of thylakoid cells and increase of thylakoid stroma, and the clinical manifestations are hematuria, proteinuria, renal dysfunction and so on, which are divided into two kinds: primary and secondary.
The prognosis of thylakoid intracapillary proliferative glomerulonephritis is poor, but the early use of combination therapy according to its clinical manifestations and pathological changes can improve or stabilize renal function to a certain extent and improve the survival rate.
Patients with thylakoid intracapillary proliferative glomerulonephritis should go to the hospital in time and be treated under the guidance of specialized physicians.